170 related articles for article (PubMed ID: 33537785)
1. Changes in For-Profit Medication-Assisted Therapy Clinics in an Appalachian City.
Holt HD; Olsen M
South Med J; 2021 Feb; 114(2):70-72. PubMed ID: 33537785
[TBL] [Abstract][Full Text] [Related]
2. Provision of Buprenorphine to Pregnant Women by For-Profit Clinics in an Appalachian City.
Walker JJ; Olsen ME
South Med J; 2018 Oct; 111(10):575-578. PubMed ID: 30285261
[TBL] [Abstract][Full Text] [Related]
3. Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states.
Patrick SW; Buntin MB; Martin PR; Scott TA; Dupont W; Richards M; Cooper WO
Subst Abus; 2019; 40(3):356-362. PubMed ID: 29949454
[No Abstract] [Full Text] [Related]
4. Prevention of Neonatal Abstinence Syndrome in an Outpatient Prenatal Buprenorphine Tapering Program.
Olsen M
South Med J; 2020 Nov; 113(11):553-558. PubMed ID: 33140108
[TBL] [Abstract][Full Text] [Related]
5. Opioid use disorder during pregnancy in Tennessee: expediency vs. science.
Martin PR; Finlayson AJ
Am J Drug Alcohol Abuse; 2015; 41(5):367-70. PubMed ID: 26186388
[TBL] [Abstract][Full Text] [Related]
6. Proliferation of Cash-Only Buprenorphine Treatment Clinics: A Threat to the Nation's Response to the Opioid Crisis.
Van Zee A; Fiellin DA
Am J Public Health; 2019 Mar; 109(3):393-394. PubMed ID: 30726142
[No Abstract] [Full Text] [Related]
7. Pharmacological treatment of opioid use disorder in pregnancy.
Rodriguez CE; Klie KA
Semin Perinatol; 2019 Apr; 43(3):141-148. PubMed ID: 30755340
[TBL] [Abstract][Full Text] [Related]
8. The Comprehensive Addiction and Recovery Act: Opioid Use Disorder and Midwifery Practice.
Murphy J; Goodman D; Johnson MC; Terplan M
Obstet Gynecol; 2018 Mar; 131(3):542-544. PubMed ID: 29420414
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine charges to uninsured patients at top-ranked U.S. hospitals.
Niforatos JD; Dorner SC; Pescatore RM; Raja AS
Am J Emerg Med; 2019 Dec; 37(12):2253-2254. PubMed ID: 31047741
[No Abstract] [Full Text] [Related]
10. Autonomous Care Pathway to Patient Opioid Abstinence: Should All Programs Offer this Approach?
Patel A; Dietz P; Casto A; DePond J; Taylor L; Seybold D; Blake A; Calhoun B
Issues Law Med; 2021; 36(2):193-210. PubMed ID: 36629776
[TBL] [Abstract][Full Text] [Related]
11. Financial factors and the implementation of medications for treating opioid use disorders.
Knudsen HK; Roman PM
J Addict Med; 2012 Dec; 6(4):280-6. PubMed ID: 22810057
[TBL] [Abstract][Full Text] [Related]
12. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
[TBL] [Abstract][Full Text] [Related]
13. Opioid Use Disorder and Pregnancy.
O'Donnell FT; Jackson DL
Mo Med; 2017; 114(3):181-186. PubMed ID: 30228577
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine and methadone for opioid addiction during pregnancy.
Mozurkewich EL; Rayburn WF
Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy.
Mittal L; Suzuki J
Subst Abus; 2017; 38(3):261-264. PubMed ID: 26672650
[TBL] [Abstract][Full Text] [Related]
16. Opioid Use Disorder in Pregnancy.
Roper V; Cox KJ
J Midwifery Womens Health; 2017 May; 62(3):329-340. PubMed ID: 28561914
[TBL] [Abstract][Full Text] [Related]
17. Methadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma.
Holbrook AM
Am J Drug Alcohol Abuse; 2015; 41(5):371-3. PubMed ID: 26154531
[TBL] [Abstract][Full Text] [Related]
18. Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16.
Yang JC; Roman-Urrestarazu A; Brayne C
PLoS One; 2020; 15(3):e0229787. PubMed ID: 32126120
[TBL] [Abstract][Full Text] [Related]
19. Pregnant Patients Using Opioids: Treatment Access Barriers in the Age of COVID-19.
Lensch AC; Hairston E; Carter G; Jones HE
J Addict Med; 2022 Jan-Feb 01; 16(1):e44-e47. PubMed ID: 33606424
[TBL] [Abstract][Full Text] [Related]
20. Medication-assisted treatment with buprenorphine: assessing the evidence.
Thomas CP; Fullerton CA; Kim M; Montejano L; Lyman DR; Dougherty RH; Daniels AS; Ghose SS; Delphin-Rittmon ME
Psychiatr Serv; 2014 Feb; 65(2):158-70. PubMed ID: 24247147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
